Sponsor pipeline

United Therapeutics clinical trial pipeline

Get alerts when United Therapeutics's trials change

8 active trials 4 recruiting 3 Phase 3 4 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
2
Phase 3
3
Phase 4
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT05203510 A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid… Pulmonary Arterial Hypertension Active, Not Recruiting 2025-12-09
Phase 3
NCT05943535 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive… Progressive Pulmonary Fibrosis Recruiting 2026-07-13
NCT03683186 A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH… PAH Enrolling by Invitation 2026-10-06
NCT04905693 Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease Idiopathic Pulmonary Fibrosis Enrolling by Invitation 2026-10-06
Phase 1/2
NCT07224763 Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With… ESRD (End-Stage Renal Disease) Recruiting 2026-09-09
NCT06878560 Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD ESRD (End-Stage Renal Disease) Recruiting 2026-03-27
Not specified
NCT06388421 DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated… Pulmonary Hypertension Due to Lung Diseases and Hypoxia Recruiting 2026-08-26
NCT03045029 ADAPT - A Patient Registry of the Real-world Use of Orenitram® Pulmonary Arterial Hypertension Active, Not Recruiting 2026-04-02

Disease areas by active trials

Hypertension (4) · Chronic Kidney Disease (2) · Heart Disease (1) · Idiopathic Pulmonary Fibrosis (1)

Get alerts when United Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free